142
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Treatment of fulminant ulcerative colitis with cyclosporine A

, &
Pages 1310-1314 | Received 12 Jun 2009, Accepted 30 Jul 2009, Published online: 06 Nov 2009

References

  • Podolsky DK. Inflammatory bowel disease N Engl J Med 2002;347:417–29.
  • Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis Gut 1963;4:299–315.
  • Modigliani R. Medical management of fulminant colitis Inflamm Bowel Dis 2002;8:129–34.
  • Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis Lancet 1974;1:1067–70.
  • Jarnerot G, Rolny P, Sandberg-Gertzen H. Intensive intravenous treatment of ulcerative colitis Gastroenterology 1985;89:1005–13.
  • Gupta S, Keshavarzian A, Hodgson HJ. Cyclosporin in ulcerative colitis Lancet 1984;2:1277–8.
  • Durai D, Hawthorne AB. Review article: how and when to use cyclosporin in ulcerative colitis Aliment Pharmacol Ther 2005;22:907–16.
  • Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Cyclosporine in severe ulcerative colitis refractory to steroid therapy N Engl J Med 1994;330:1841–5.
  • Actis GC, Fadda M, David E, Sapino A. Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study BMC Gastroenterol 2007;7:13.
  • Campbell S, Travis S, Jewell D. Cyclosporin use in acute ulcerative colitis: a long-term experience Eur J Gastroenterol Hepatol 2005;17:79–84.
  • Chapman RW, Selby WS, Jewell DP. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis Gut 1986;27:1210–2.
  • Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial Br Med J 1955;2:1041–8.
  • Campbell S, Ghosh S. Combination immunomodulatory therapy with cyclosporine and azathioprine in corticosteroid-resistant severe ulcerative colitis: the Edinburgh experience of outcome Dig Liver Dis 2003;35:546–51.
  • Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: a five-year experience Am J Gastroenterol 1999;94:1587–92.
  • Arts J, D'Haens G, Zeegers M, Van AG, Hiele M, D'Hoore A, Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis Inflamm Bowel Dis 2004;10:73–8.
  • Moskovitz DN, Van AG, Maenhout B, Arts J, Ferrante M, Vermeire S, Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis Clin Gastroenterol Hepatol 2006;4:760–5.
  • Caprilli R, Viscido A, Latella G. Current management of severe ulcerative colitis Natl Clin Pract Gastroenterol Hepatol 2007;4:92–101.
  • Feutren G, Mihatsch MJ. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases N Engl J Med 199218;326:1654–60.
  • Van AG, D'Haens G, Noman M, Vermeire S, Hiele M, Asnong K, Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis Gastroenterology 2003;125:1025–31.
  • Jarnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlen P, Granno C, Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study Gastroenterology 2005;128:1805–11.
  • Regueiro M, Curtis J, Plevy S. Infliximab for hospitalized patients with severe ulcerative colitis J Clin Gastroenterol 2006;40:476–81.
  • Aratari A, Papi C, Clemente V, Moretti A, Luchetti R, Koch M, Colectomy rate in acute severe ulcerative colitis in the infliximab era Dig Liver Dis 2008;40:821–6.
  • Gisbert JP, Gonzalez-Lama Y, Mate J. Systematic review: Infliximab therapy in ulcerative colitis Aliment Pharmacol Ther 2007;25:19–37.
  • Kohn A, Daperno M, Armuzzi A, Cappello M, Biancone L, Orlando A, Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up Aliment Pharmacol Ther 2007;26:747–56.
  • Lees CW, Heys D, Ho GT, Noble CL, Shand AG, Mowat C, A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis Aliment Pharmacol Ther 2007;26:411–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.